5 hrs ago | Reuters
BTG builds interventional medicine platform with deals
Britain's BTG said it would make two acquisitions, one extending its expertise in liver cancer and the other a treatment for severe blood clots, to create an interventional medicine business with potential sales of $1 billion.
9 hrs ago | Customer Interaction Solutions
Nordion Enters into Agreement to Divest Targeted Therapies Business to BTG plc
Nordion Inc. , a leading provider of products and services for the prevention, diagnosis and treatment of disease, announced that it has entered into an agreement to divest its Targeted Therapies business to BTG plc , an international specialist healthcare company based in London, United Kingdom, for a cash purchase price of US$200 million.
Hepatitis C: A 21st Century Success Story
Hepatitis C has been called a silent epidemic: As the most common blood-borne viral infection in the country, it affects more than 7 million Americans - yet, most don't know they have it.
County concerned by Hepatitis C rise in Baby Boomers
In the first four months of the year, Franklin County already reported 63 percent of the number of Hepatitis C cases identified in 2012, significantly more than in other years, Midge Ransom, Franklin County health department director, said.
Onyx Pharmaceuticals' Management Presents at UBS Global Healthcare Conference
Hello and good morning. My name is Andrew Peters, and I'm on the biotech equity research team here at UBS.
Cellular Biomedicine Group Announces Enrollment Milestone for Phase I ...
To date the trial has had no Severe Adverse Effect reported. The Phase I clinical trial for TC-DC therapy for HCC, registered with NIH under number NCT01828762 is an open label clinical trial conducted with 's PLA 85 Hospital, one of the Liver Disease Centers of People's Liberation Army.
European Medicines Agency Validates Gilead's Marketing Application...
Gilead Sciences, Inc. today announced that the company's Marketing Authorisation Application for sofosbuvir, a once-daily oral nucleotide analogue inhibitor for the treatment of chronic hepatitis C virus infection, which was submitted to the European Medicines Agency on April 17, 2013, has been fully validated and is now under assessment.
Medal winning cyclist launches charity ride for Norfolk hospital appeal
A medal winning professional cyclist helped launch a charity ride at the weekend for a cause close to her heart.
HIV Is No Barrier To Successful Liver Transplant For Cancer Treatment
As people infected with HIV live longer with antiretroviral drug therapy, more of them are developing hepatocellular carcinoma , which is particularly aggressive among this population.
Benefit for Tennis Coach Tonight
The tennis coach at Alton High School is battling liver cancer, and a benefit is being held tonight.
Hep C rising in baby boomers, but can they be treated?
When Amtrak unveils the first of 70 new locomotives Monday at a plant in California, it will mark what the national passenger railroad service hopes will be a new era of better reliability, streamlined maintenance and better energy efficiency.
HIV No Barrier to Getting Liver Transplant, Study Finds
Liver transplants to treat a common type of liver cancer are a viable option for people infected with HIV, according to new research.
Leading up to The Relay For Life events in June, Action News will introduce you to different people in the community, impacted by cancer.
Proceeds to help boy with rare form of cancer
Anna Hays Polk, 4, serves up some fresh lemonade at her home to Charlene Jackson on Wednesday.
Hepatitis C virus major challenge in the region
DOHA: About 150 million people are chronically infected and at risk of developing liver cirrhosis and/or liver cancer, and more than 350,000 people die from Hepatitis C Virus related liver diseases every year, Dr Laith Abu-Raddad said last night at a community health forum in Doha.
Fairfield High School students are using a novel art project to help beat hepatitis B and reduce the burden of liver cancer in the local area.
Centre will assist Hepatitis C patients
Health advocates expect more baby boomers will screen for Hepatitis C, with the opening of a long-awaited treatment and support centre.
Bayer Initiates Phase III Trial of Stivarga? (regorafenib) Tablets in ...
Stivarga is an inhibitor of multiple kinases involved in normal cellular functions and in pathologic processes such as oncogenesis, tumor angiogenesis and maintenance of the tumor microenvironment.1 , the FDA approved Stivarga to treat patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumor who have been previously ... (more)
Brave tot from Benfleet is battling one in a million cancer
A BRAVE tot from Benfleet is battling a form of liver cancer so rare it only affects one in a million children.
Screening Events Promote Hepatitis Testing and Prevention during National Hepatitis Awareness Month
Duringi 1 2National Hepatitis Awareness Month this May,i 1 2Hep B Free San Francisco, Asian Week Foundation, and National Viral Hepatitis Roundtable are helping to coordinate hepatitis screenings and a new public service announcement to highlight prevention of hepatitis B and C disease, which together cause almost all liver cancers worldwide.i ... (more)